Gert‐Jan van Baaren

Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial

Kim Broekhuijsen, Gert‐Jan van Baaren, Maria G. van Pampus et al. · The Lancet · 2015 · 204 citations

Public Health, Maternal Health, Obstetrics +13

Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT-II): a multicentre randomised controlled non-inferiority trial

Mieke Ten Eikelder, Katrien Oude Rengerink, Marta Jozwiak et al. · The Lancet · 2016 · 122 citations

Nursing, Maternal Health, Obstetrics +8

The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women

Merel Bruijn, Esmé Kamphuis, Irène Hoesli et al. · American Journal of Obstetrics and Gynecology · 2016 · 71 citations · Full text

Medicine, Gynecology, Obstetrics +10

Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor

Gert‐Jan van Baaren, Jolande Vis, William A. Grobman et al. · American Journal of Obstetrics and Gynecology · 2013 · 43 citations

Medicine, Gynecology, Obstetrics +16

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial

Josje Langenveld, Kim Broekhuijsen, Gert‐Jan van Baaren et al. · BMC Pregnancy and Childbirth · 2011 · 40 citations · Full text

Public Health, Maternal Health, Obstetrics +17